235 related articles for article (PubMed ID: 30296244)
1. Mining Directional Drug Interaction Effects on Myopathy Using the FAERS Database.
Chasioti D; Yao X; Zhang P; Lerner S; Quinney SK; Ning X; Li L; Shen L
IEEE J Biomed Health Inform; 2019 Sep; 23(5):2156-2163. PubMed ID: 30296244
[TBL] [Abstract][Full Text] [Related]
2. Mining and visualizing high-order directional drug interaction effects using the FAERS database.
Yao X; Tsang T; Sun Q; Quinney S; Zhang P; Ning X; Li L; Shen L
BMC Med Inform Decis Mak; 2020 Mar; 20(Suppl 2):50. PubMed ID: 32183790
[TBL] [Abstract][Full Text] [Related]
3. Mixture drug-count response model for the high-dimensional drug combinatory effect on myopathy.
Wang X; Zhang P; Chiang CW; Wu H; Shen L; Ning X; Zeng D; Wang L; Quinney SK; Feng W; Li L
Stat Med; 2018 Feb; 37(4):673-686. PubMed ID: 29171062
[TBL] [Abstract][Full Text] [Related]
4. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
[TBL] [Abstract][Full Text] [Related]
5. Propensity score-adjusted three-component mixture model for drug-drug interaction data mining in FDA Adverse Event Reporting System.
Wang X; Li L; Wang L; Feng W; Zhang P
Stat Med; 2020 Mar; 39(7):996-1010. PubMed ID: 31880829
[TBL] [Abstract][Full Text] [Related]
6. Mining clinical text for signals of adverse drug-drug interactions.
Iyer SV; Harpaz R; LePendu P; Bauer-Mehren A; Shah NH
J Am Med Inform Assoc; 2014; 21(2):353-62. PubMed ID: 24158091
[TBL] [Abstract][Full Text] [Related]
7. Translational High-Dimensional Drug Interaction Discovery and Validation Using Health Record Databases and Pharmacokinetics Models.
Chiang CW; Zhang P; Wang X; Wang L; Zhang S; Ning X; Shen L; Quinney SK; Li L
Clin Pharmacol Ther; 2018 Feb; 103(2):287-295. PubMed ID: 29052226
[TBL] [Abstract][Full Text] [Related]
8. Graphic Mining of High-Order Drug Interactions and Their Directional Effects on Myopathy Using Electronic Medical Records.
Du L; Chakraborty A; Chiang CW; Cheng L; Quinney SK; Wu H; Zhang P; Li L; Shen L
CPT Pharmacometrics Syst Pharmacol; 2015 Aug; 4(8):481-8. PubMed ID: 26380157
[TBL] [Abstract][Full Text] [Related]
9. A Modified Skip-Gram Algorithm for Extracting Drug-Drug Interactions from AERS Reports.
Wang L; Pan W; Wang Q; Bai H; Liu W; Jiang L; Zhang Y
Comput Math Methods Med; 2020; 2020():1747413. PubMed ID: 32351611
[TBL] [Abstract][Full Text] [Related]
10. Mining heterogeneous networks with topological features constructed from patient-contributed content for pharmacovigilance.
Yang CC; Yang H
Artif Intell Med; 2018 Aug; 90():42-52. PubMed ID: 30093253
[TBL] [Abstract][Full Text] [Related]
11. An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval.
Lorberbaum T; Sampson KJ; Woosley RL; Kass RS; Tatonetti NP
Drug Saf; 2016 May; 39(5):433-41. PubMed ID: 26860921
[TBL] [Abstract][Full Text] [Related]
12. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
[TBL] [Abstract][Full Text] [Related]
13. A pharmacovigilance study of pharmacokinetic drug interactions using a translational informatics discovery approach.
Wang L; Shendre A; Chiang CW; Cao W; Ning X; Zhang P; Zhang P; Li L
Br J Clin Pharmacol; 2022 Feb; 88(4):1471-1481. PubMed ID: 33543792
[TBL] [Abstract][Full Text] [Related]
14. Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports.
Cai R; Liu M; Hu Y; Melton BL; Matheny ME; Xu H; Duan L; Waitman LR
Artif Intell Med; 2017 Feb; 76():7-15. PubMed ID: 28363289
[TBL] [Abstract][Full Text] [Related]
15. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
[TBL] [Abstract][Full Text] [Related]
16. Incorporating User Generated Content for Drug Drug Interaction Extraction Based on Full Attention Mechanism.
Xu B; Shi X; Yin Y; Zhao Z; Zheng W; Lin H; Yang Z; Wang J; Xia F
IEEE Trans Nanobioscience; 2019 Jul; 18(3):360-367. PubMed ID: 31144641
[TBL] [Abstract][Full Text] [Related]
17. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.
Dechanont S; Maphanta S; Butthum B; Kongkaew C
Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171
[TBL] [Abstract][Full Text] [Related]
18. Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS.
Fujimoto M; Hosomi K; Takada M
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):259-66. PubMed ID: 24472404
[TBL] [Abstract][Full Text] [Related]
19. Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data.
Zhan C; Roughead E; Liu L; Pratt N; Li J
J Biomed Inform; 2020 Dec; 112():103603. PubMed ID: 33153975
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and nature of statin drug-drug interactions in a university hospital by electronic health record mining.
Morival C; Westerlynck R; Bouzillé G; Cuggia M; Le Corre P
Eur J Clin Pharmacol; 2018 Apr; 74(4):525-534. PubMed ID: 29255993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
